[go: up one dir, main page]

TNSN97039A1 - Derives d'oxadiazole et de thiadiazole antagonistes des recepteurs muscariniques. - Google Patents

Derives d'oxadiazole et de thiadiazole antagonistes des recepteurs muscariniques.

Info

Publication number
TNSN97039A1
TNSN97039A1 TNTNSN97039A TNSN97039A TNSN97039A1 TN SN97039 A1 TNSN97039 A1 TN SN97039A1 TN TNSN97039 A TNTNSN97039 A TN TNSN97039A TN SN97039 A TNSN97039 A TN SN97039A TN SN97039 A1 TNSN97039 A1 TN SN97039A1
Authority
TN
Tunisia
Prior art keywords
antagonists
muscarinic receptors
thiadiazole
oxadiazole
derivatives
Prior art date
Application number
TNTNSN97039A
Other languages
English (en)
Inventor
Roderick Mackenzie Alexander
Wood Anthony
John Bass Robert
Original Assignee
Pfizer Res And Dev Company Nv S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res And Dev Company Nv S A filed Critical Pfizer Res And Dev Company Nv S A
Publication of TNSN97039A1 publication Critical patent/TNSN97039A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

L'INVENTION CONCERNE UN COMPOSE DE FORMULE I : DANS LAQUELLE R1 ET R3 REPRESENTENT DES RADICAUX ORGANIQUES. R2 REPRESENTE H OU UN RADICAL ORGANIQUE , X REPRESENTE O OU S ET Y REPRESENTE UNE LIAISON DIRECTE OU UN RADICAL ORGANIQUE, ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LA PREPARATION D'UN TEL COMPOSE ET UNE COMPOSITION PHARMACEUTIQUE COMPRENANT CE COMPOSE. UTILISATION DES COMPOSES COMME ANTAGONISTES DES RECEPTEURS MUSCARINIQUES DANS LE TRAITEMENT DE DIVERSES MALADIES.
TNTNSN97039A 1996-02-22 1997-02-19 Derives d'oxadiazole et de thiadiazole antagonistes des recepteurs muscariniques. TNSN97039A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603755.1A GB9603755D0 (en) 1996-02-22 1996-02-22 Therapeutic agents

Publications (1)

Publication Number Publication Date
TNSN97039A1 true TNSN97039A1 (fr) 2005-03-15

Family

ID=10789217

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN97039A TNSN97039A1 (fr) 1996-02-22 1997-02-19 Derives d'oxadiazole et de thiadiazole antagonistes des recepteurs muscariniques.

Country Status (42)

Country Link
US (1) US5977142A (fr)
EP (1) EP0885218B1 (fr)
JP (1) JP3148252B2 (fr)
KR (1) KR100315934B1 (fr)
CN (1) CN1089340C (fr)
AP (1) AP751A (fr)
AR (1) AR005916A1 (fr)
AT (1) ATE200899T1 (fr)
AU (1) AU712230B2 (fr)
BG (2) BG63971B1 (fr)
BR (1) BR9707733A (fr)
CA (1) CA2247164C (fr)
CO (1) CO4650040A1 (fr)
CZ (1) CZ292650B6 (fr)
DE (1) DE69704701T2 (fr)
DK (1) DK0885218T3 (fr)
DZ (1) DZ2181A1 (fr)
ES (1) ES2156357T3 (fr)
GB (1) GB9603755D0 (fr)
GR (1) GR3036032T3 (fr)
HN (1) HN1997000020A (fr)
HR (1) HRP970098B1 (fr)
HU (1) HUP9900501A3 (fr)
ID (1) ID16642A (fr)
IL (1) IL125413A (fr)
IS (1) IS4803A (fr)
MY (1) MY129729A (fr)
NO (1) NO313414B1 (fr)
NZ (1) NZ331039A (fr)
OA (1) OA10838A (fr)
PE (1) PE42798A1 (fr)
PL (1) PL186879B1 (fr)
PT (1) PT885218E (fr)
RU (1) RU2162848C2 (fr)
SK (1) SK283461B6 (fr)
TN (1) TNSN97039A1 (fr)
TR (1) TR199801644T2 (fr)
TW (1) TW492961B (fr)
UA (1) UA61068C2 (fr)
WO (1) WO1997030994A1 (fr)
YU (1) YU35698A (fr)
ZA (1) ZA971513B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
UA74419C2 (uk) * 2001-02-21 2005-12-15 Ен Пі Ес Фармасьютікалс, Інк. Заміщені піридини та їх застосування як антагоністів рецептору метаботропного глутамату
GB0510141D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
GB0510139D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
GB0516313D0 (en) * 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2008017827A2 (fr) * 2006-08-08 2008-02-14 Argenta Discovery Limited Composés chimiques
WO2008023157A1 (fr) * 2006-08-21 2008-02-28 Argenta Discovery Limited Composés et leur utilisation
WO2008096093A1 (fr) * 2007-02-06 2008-08-14 Argenta Discovery Ltd. Dérivés d'oxazole et de thiazole et leurs utilisations
GB0702414D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd Oxazole and thiazole derivatives and their uses 2
GB0702416D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
GB0702385D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
GB0702382D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New salt
CA2675629A1 (fr) * 2007-02-07 2008-08-14 Argenta Discovery Ltd Sel inedit
NZ578489A (en) * 2007-02-15 2011-05-27 Pulmagen Therapeutics Synergy Heterocyclic derivatives as m3 muscarinic receptors
WO2009098453A1 (fr) * 2008-02-06 2009-08-13 Astrazeneca Ab Azonia bicycloalcanes comme antagonistes du récepteur d'acétylcholine muscarinique m3
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
WO2010018352A1 (fr) * 2008-08-12 2010-02-18 Argenta Discovery Limited Composés hétérocycliques utilisés dans le traitement de maladies impliquant l’activation améliorée du récepteur m3
JP2014065387A (ja) * 2012-09-25 2014-04-17 Showa Corp 自動二輪車の車高調整装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
WO1993013083A1 (fr) * 1991-12-31 1993-07-08 Fujisawa Pharmaceutical Co., Ltd. Derives d'oxadiazole a effet inhibiteur de l'acetylcholinesterase et agoniste muscarinique
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

Also Published As

Publication number Publication date
AU712230B2 (en) 1999-11-04
CN1211981A (zh) 1999-03-24
GB9603755D0 (en) 1996-04-24
BR9707733A (pt) 1999-07-27
ATE200899T1 (de) 2001-05-15
KR19990087143A (ko) 1999-12-15
MY129729A (en) 2007-04-30
OA10838A (en) 2001-08-13
UA61068C2 (en) 2003-11-17
DE69704701T2 (de) 2001-08-16
PT885218E (pt) 2001-08-30
JPH11504051A (ja) 1999-04-06
HK1018274A1 (en) 1999-12-17
CA2247164A1 (fr) 1997-08-28
AR005916A1 (es) 1999-07-21
HUP9900501A2 (hu) 1999-06-28
NO313414B1 (no) 2002-09-30
PE42798A1 (es) 1998-08-18
ID16642A (id) 1997-10-23
CO4650040A1 (es) 1998-09-03
EP0885218A1 (fr) 1998-12-23
DZ2181A1 (fr) 2002-12-01
BG63971B1 (bg) 2003-08-29
JP3148252B2 (ja) 2001-03-19
HN1997000020A (es) 1997-06-05
GR3036032T3 (en) 2001-09-28
YU35698A (sh) 1999-07-28
CZ267898A3 (cs) 1999-08-11
HRP970098B1 (en) 2001-12-31
IS4803A (is) 1998-07-21
CZ292650B6 (cs) 2003-11-12
AU1601497A (en) 1997-09-10
DE69704701D1 (de) 2001-06-07
SK283461B6 (sk) 2003-08-05
AP9700930A0 (en) 1997-04-30
BG102699A (en) 1999-09-30
RU2162848C2 (ru) 2001-02-10
CA2247164C (fr) 2004-11-16
PL328633A1 (en) 1999-02-15
PL186879B1 (pl) 2004-03-31
DK0885218T3 (da) 2001-05-28
TW492961B (en) 2002-07-01
US5977142A (en) 1999-11-02
TR199801644T2 (xx) 1998-11-23
IL125413A0 (en) 1999-03-12
KR100315934B1 (ko) 2002-03-21
NO983871L (no) 1998-08-21
EP0885218B1 (fr) 2001-05-02
AP751A (en) 1999-07-12
IL125413A (en) 2002-09-12
ES2156357T3 (es) 2001-06-16
NO983871D0 (no) 1998-08-21
SK112398A3 (en) 2000-04-10
CN1089340C (zh) 2002-08-21
HUP9900501A3 (en) 2001-02-28
WO1997030994A1 (fr) 1997-08-28
NZ331039A (en) 1999-10-28
ZA971513B (en) 1998-08-21
HRP970098A2 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
TNSN97039A1 (fr) Derives d'oxadiazole et de thiadiazole antagonistes des recepteurs muscariniques.
TNSN98148A1 (fr) 4-aminopyrrole (3,2-d) pyrimidines servant d'antagonistes des recepteurs de neuropeptide y
CA2244785A1 (fr) Pentafluorobenzenesulfonamides et analogues
TNSN99125A1 (fr) Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98112A1 (fr) Composes dipeptidiques
MA26718A1 (fr) Derives de quinoleine-2-one a substituant heteroaryle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN96161A1 (fr) Derives de la quinoleine et de quinazoline nouveaux procede pour leur preparation et formulations pharmaceutiques les contenant.
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant
MA21896A1 (fr) Procede de prepatration d'acides imidazolyl - alcenoiques .
TNSN96174A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant.
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
TNSN97139A1 (fr) Derives d'acides d'arylsulfonylaminohydroxamiques
TNSN97192A1 (fr) Derives de pyrimidine bicycliques condenses, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2258949A1 (fr) Nouveaux composes heterocycliques, leur procede de preparation, compositions pharmaceutiques les contenant et utilisation de ces composes dans le traitement du diabete et des maladies associees
TNSN97044A1 (fr) Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant.
ATE89547T1 (de) Dopamin-vorlaeufer.
TNSN98151A1 (fr) Derives de 2 - (4 - aryl - ou heteroaryl - piperazine - 1 - ylmethyl) -1 h - indole.
TNSN98185A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99255A1 (fr) Derives de piperidine et de morpholine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00250A1 (fr) Composes nouveaux inhibiteurs de pcp, procede pour leur preparation et compositions les contenant
RU94046141A (ru) Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция
MA26541A1 (fr) Nouvelles imidazolines, procede pour les preparer, compositions pharmaceutiques les contenant et leur utilisation dans le traitement de maladies soulagees par un traitement avec un antagoniste des recepteurs des prostaglandines
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença